ABSTRACT
Pediatric infections still represent a leading cause of mortality in many developing countries. Since ancient times, traditional healing systems provided some herbal remedies to treat pediatric diseases, only in some cases validated by an evidence-based approach. Therefore, this review covers the herbal remedies in Iranian traditional medicine and aims to assess the potential of phytotherapeutics as safe and effective alternatives to conventional therapies for the treatment of pediatric infectious diseases. Notably, pediatric patients may also benefit from adjuvant therapy, i.e., combined treatment with herbal remedies and conventional therapies, to improve the efficacy of conventional drugs, decrease their adverse effects at the cell-tissue-organ-organism level and reduce the occurrence of microbial strains resistant to antibiotics. Therefore, traditional healing systems still represent an unlimited source of active ingredients to be tested in preclinical assays as well as in humans in terms of efficacy and safety.
Subject(s)
Communicable Diseases/drug therapy , Phytotherapy , Child , Clinical Trials as Topic , Humans , Medicine, Traditional , Phytochemicals/chemistry , Phytochemicals/pharmacologyABSTRACT
The present study focused on the elucidation of the putative anticancer potential of quercetin. The anticancer activity of quercetin at 10, 20, 40, 80 and 120 µM was assessed in vitro by MMT assay in 9 tumor cell lines (colon carcinoma CT26 cells, prostate adenocarcinoma LNCaP cells, human prostate PC3 cells, pheocromocytoma PC12 cells, estrogen receptorpositive breast cancer MCF7 cells, acute lymphoblastic leukemia MOLT4 Tcells, human myeloma U266B1 cells, human lymphoid Raji cells and ovarian cancer CHO cells). Quercetin was found to induce the apoptosis of all the tested cancer cell lines at the utilized concentrations. Moreover, quercetin significantly induced the apoptosis of the CT26, LNCaP, MOLT4 and Raji cell lines, as compared to control group (P<0.001), as demonstrated by Annexin V/PI staining. In in vivo experiments, mice bearing MCF7 and CT26 tumors exhibited a significant reduction in tumor volume in the quercetintreated group as compared to the control group (P<0.001). Taken together, quercetin, a naturally occurring compound, exhibits anticancer properties both in vivo and in vitro.
Subject(s)
Apoptosis/drug effects , Cell Proliferation/drug effects , Neoplasms/drug therapy , Quercetin/administration & dosage , Animals , Cell Line, Tumor , Humans , MCF-7 Cells , Mice , Neoplasms/genetics , Neoplasms/pathology , Xenograft Model Antitumor AssaysABSTRACT
The cytochrome P450 (CYP) family is the principal enzyme system involved in the metabolism of xenobiotics and endogenous compounds. Among this family, CYP2A6 is one of the most important enzymes for metabolism of nicotine. In this study, the linkage of CYP2A6*1 and CYP2A6*4 genotypes with nicotine metabolism was investigated. A single polymerase chain reaction-restriction fragment length polymorphism was used to resolve the genotypes into CYP2A6*1 (wild type), CYP2A6*2, or CYP2A6*3. The population studied consisted of 200 healthy smokers from Mashhad city, North East of Iran. The urinary cotinine as the principal metabolite of nicotine was analyzed for 12 subjects (7 subjects with CYP2A6*1 as controls and 5 subjects with CYP2A6*4). The results indicated that cumulative urinary cotinine excretion in CYP2A6*4 genotype was about one-eighth compared with the control group (wild type). Cotinine formation from nicotine has individual and ethnic variability that correlated with the level of CYP2A6 expression. Moreover, urinary cotinine level was drastically lower in CYP2A6*4 subjects than in CYP2A6*1 subjects.